Login to Your Account


Nybo Therapeutics launches, aims MAbs at pancreatic cancer

By Nuala Moran
Staff Writer

Tuesday, April 11, 2017

LONDON – Technology commercialization specialist Puretech Health plc has launched start-up, Nybo Therapeutics, to discover and develop monoclonal antibodies that neutralize newly discovered immunosuppressive mechanisms in pancreatic cancer.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription